<DOC>
	<DOC>NCT00698828</DOC>
	<brief_summary>To evaluate SUN11031 for injection compared to placebo in subjects with cachexia associated with Chronic Obstructive Pulmonary Disease (COPD) to determine the effect on physical performance and body composition.</brief_summary>
	<brief_title>SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<criteria>Male or nonpregnant female subjects ≥50 years of age with a clinical diagnosis of COPD Loss &gt;5% of subject's usual body weight Severe anemia (hemoglobin ≤8 g/dL) COPD exacerbation Currently undergoing treatment or evaluation for cancer Type I or type II diabetes mellitus or a fasting serum glucose of ≥115 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Cachexia, COPD, Chronic Obstructive Pulmonary Disease</keyword>
</DOC>